Melanosomal and lysosomal alterations in murine melanocytes following transfection with the v-rasHa oncogene

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 557-563

  Donatien, Philippe D ^a   Diment, Stephanie L ^a   Boissy, Raymond E ^b   Orlow, Seth J ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; THIOL PROTEINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENETIC TRANSFECTION; LYSOSOME; MELANOCYTE; MELANOMA CELL; MELANOSOME; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; CATHEPSIN B; CATHEPSIN D; CATHEPSINS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, RAS; INTRAMOLECULAR OXIDOREDUCTASES; ISOMERASES; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; LYSOSOMES; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PROTEINS; TRANSFECTION;

EID: 0029889370     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<557::AID-IJC22>3.0.CO;2-3     Document Type: Article

References (22)

1. ADEMA, G.J., DE BOER, A.J., VOGEL, A.M., LOENEN, W.A.M. and FIGDOR, C.G., Molecular characterization of the melanocyte lineage-specific antigen gp 100. J. biol. Chem., 269, 20126-20133 (1994).
2. ALBINO, A.P., NANUS, D.M., MENTLE, I.R., CORDON-CARDO, C., MCNUTT, N.S., BRESSLER, J. and ANDREEFF, M., Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene, 4, 1363-1374 (1989).
3. ALBINO, A.P., SOZZI, G., NANUS, D.M., JHANWAR, S.C. and HOUGHTON, A.N., Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. Oncogene, 7, 2315-2321 (1992).
4. BALL, N.J., YOHN, J.J., MORELLI, J.G., NORRIS, D.A., GOLITZ, L.E. and HOEFFLER, J.P., Ras mutations in human melanoma: a marker of malignant progression. J. Invest. Dermatol., 102, 285-290 (1994).
5. BENNETT, D.C., COOPER, P.J., DEXTER, T.J., DEVLIN, L.M., HEASMAN, J. and NESTER, B., Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development, 105, 379-385 (1989).
6. DIMENT, S., EIDELMAN, M., RODRIGUEZ, G.M. and ORLOW, S.J., Lysosomal hydrolases are present in melanosomes and are elevated in melanizing cells. J. biol. Chem., 270, 4213-4215 (1995).
7. DIMENT, S. and SHINDE, S., Selective processing of exogenous antigens by antigen-presenting cells with deleted MHC genes. J. Immunol., 154, 530-535 (1995).
8. DONATIEN, P.D. and ORLOW, S.J., Interaction of melanosomal proteins with melanin. Europ. J. Biochem., 232, 159-164 (1995).
9. DOTTO, G.P., MOELLMANN, G., GHOSH, S., EDWARDS, M. and HALABAN, R., Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol., 109, 3115-3128 (1989).
10. ERLANDSON, R.A., Ultrastructural diagnosis of amelanotic malignant melanoma: aberrant melanosomes, myelin figures or lysosomes? Ultrastruct. Pathol., 11, 191-208 (1987).
11. HIROBE, T., Origin of melanosome structures and cytochemical localizations of tyrosinase activity in differentiating epidermal melanocytes of newborn mouse skin. J. exp. Zool., 224, 355-363 (1982).
12. JAFARI, M., PAPP, T., KIRCHNER, S., DIENER, U., HENSCHLER, D., BURG, G. and SCHIFFMANN, D., Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J. Cancer Res. clin. Oncol., 121, 23-30 (1995).
13. ORLOW, S.J., HEARING, V.J., SAKAI, C., URABE, K., ZHOU, B.K., SILVERS, W.K. and MINTZ, B., Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression. Proc. nat. Acad. Sci. (Wash.), 92, 10152-10156 (1995).
14. RAYBAUD, F., NOGUCHI, T., MARICS, I., ADELAIDE, J., PLANCHE, J., BATOZ., M., AUBERT, C., DE LAPEYRIERE, O. and BIRNBAUM, D., Detection of low frequency of activated ras genes in human melanomas using a tumorigenicity assay. Cancer Res., 48, 950-953 (1988).
15. ROSEMBLAT, S., DURHAM-PIERRE, D., GARDNER, J.M., NAKATSU, Y., BRILLIANT, M.H. and ORLOW, S.J., Identification of a melanosomal membrane protein encoded by the pink eyed dilution (type II occulocutaneous albinism) gene. Proc. nat. Acad. Sci. (Wash.), 91, 12071-12075 (1994).
16. SHI, G.P., MUNGER, J.S., MEARA, J.P., RICH, D.H. and CHAPMAN, H., Molecular cloning and expression of human macrophage cathepsin S, an elastinolytic cysteine protease. J. biol. Chem., 267, 7258-7262 (1992).
17. SLOANE, B.F., MOIN, K., KREPELA, E. and ROZHIN, J., Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metastasis Rev., 9, 333-352 (1990).
18. HA oncogene. Pigment Cell Res., Suppl. 2, 181-184 (1992).
19. WAGNER, S.N., OCKENFELS, H.M., WAGNER, C., HÖFLER, H. and GOOS, M., Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. J. Invest. Dermatol., 104, 868-871 (1995).
20. WILSON, R.E., DOOLEY, T.P. and HART, I.R., Induction of tumorigenicity and lack of in vitro growth requirement for 12-O-tetradecanoylphorbol-13-acetate by transfection of murine melanocytes with v-Ha-ras. Cancer Res., 49, 711-716 (1989).
21. YASUDA, H., KOBAYASHI, H., OHKAWARA, A. and KUZUMAKI, N., Differential expression of ras oncogene products among the types of human melanomas and melanocytic nevi. J. Invest. Dermatol., 93, 54-59 (1989).
22. ZHOU, B., KOBAYASHI, T., DONATIEN, P.D., BENNETT, D.C, HEARING, V.J. and ORLOW, S.J., Identification of a melanosomal matrix protein encoded by the murine si (silver) locus using "organelle scanning". Proc. nat. Acad. Sci. (Wash.), 91, 7076-7080 (1994).